Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L
文献类型:期刊论文
作者 | Li, Xin4,5; Wu, Xiaowei2,3,5; Nie, Shenyou1,5; Zhao, Jidong5; Yao, Yuan5; Wu, Fangrui5; Mishra, Chandra Bhushan5; Ashraf-Uz-Zaman, Md5; Moku, Bala Krishna5; Song, Yongcheng4,5 |
刊名 | CANCERS
![]() |
出版日期 | 2023-11-01 |
卷号 | 15期号:21页码:28 |
关键词 | MLL-rearranged leukemia super elongation complexes small-molecule inhibitor protein-protein interaction cancer therapeutics |
DOI | 10.3390/cancers15215283 |
通讯作者 | Song, Yongcheng(ysong@bcm.edu) |
英文摘要 | Simple Summary: Chromosomal translocations involving the mixed lineage leukemia (MLL) gene generate potent fusion oncogenes and cause acute myeloid leukemia or lymphocytic leukemia, which account for similar to 75% infant and 5-10% child/adult acute leukemia cases with a poor prognosis (5-year survival rates < 45%). Protein-protein interactions between the most frequent MLL fusion partner proteins AF9/ENL and AF4 or histone methyltransferase DOT1L are critical to malignant gene expression and are therefore a potential drug target for cancer. Compound screening followed by medicinal chemistry studies identified several novel small-molecule inhibitors showing strong inhibition of these protein-protein interactions, significant suppression of characteristic gene expression, and robust cellular anticancer activities with negligible cytotoxicity. These compounds are useful chemical probes for biological studies of these protein-protein interactions, as well as pharmacological leads for further drug development against MLL-rearranged and other leukemias. Chromosomal translocations involving the mixed lineage leukemia (MLL) gene cause 5-10% acute leukemias with poor clinical outcomes. Protein-protein interactions (PPI) between the most frequent MLL fusion partner proteins AF9/ENL and AF4 or histone methyltransferase DOT1L are drug targets for MLL-rearranged (MLL-r) leukemia. Several benzothiophene-carboxamide compounds were identified as novel inhibitors of these PPIs with IC50 values as low as 1.6 mu M. Structure-activity relationship studies of 77 benzothiophene and related indole and benzofuran compounds show that a 4-piperidin-1-ylphenyl or 4-pyrrolidin-1-ylphenyl substituent is essential for the activity. The inhibitors suppressed expression of MLL target genes HoxA9, Meis1 and Myc, and selectively inhibited proliferation of MLL-r and other acute myeloid leukemia cells with EC50 values as low as 4.7 mu M. These inhibitors are useful chemical probes for biological studies of AF9/ENL, as well as pharmacological leads for further drug development against MLL-r and other leukemias. |
WOS关键词 | ACUTE LYMPHOBLASTIC-LEUKEMIA ; ACUTE MYELOID-LEUKEMIA ; GENE-EXPRESSION ; MLL GENE ; REARRANGEMENTS ; PARTNERS ; CANCER ; MYC ; TRANSLOCATIONS ; METHYLATION |
资助项目 | United States National Institute of Health/National Cancer Institute[R01CA266057] ; Cancer Prevention and Research Institute of Texas[RP220232] |
WOS研究方向 | Oncology |
语种 | 英语 |
WOS记录号 | WOS:001103366300001 |
出版者 | MDPI |
源URL | [http://119.78.100.183/handle/2S10ELR8/307845] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Song, Yongcheng |
作者单位 | 1.Chongqing Med Univ, Inst Life Sci, Basic Med Res & Innovat Ctr Novel Target & Therape, Minist Educ, Chongqing 400016, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Dev Ctr, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528400, Peoples R China 4.Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, 1 Baylor Plaza, Houston, TX 77030 USA 5.Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA |
推荐引用方式 GB/T 7714 | Li, Xin,Wu, Xiaowei,Nie, Shenyou,et al. Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L[J]. CANCERS,2023,15(21):28. |
APA | Li, Xin.,Wu, Xiaowei.,Nie, Shenyou.,Zhao, Jidong.,Yao, Yuan.,...&Song, Yongcheng.(2023).Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L.CANCERS,15(21),28. |
MLA | Li, Xin,et al."Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L".CANCERS 15.21(2023):28. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。